These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 25646704)
1. Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease. Huber H; Hodolic M; Stelzmüller I; Wunn R; Hatzl M; Fellner F; Lamprecht B; Rubello D; Colletti PM; Gabriel M Nucl Med Commun; 2015 May; 36(5):430-7. PubMed ID: 25646704 [TBL] [Abstract][Full Text] [Related]
2. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
3. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694 [TBL] [Abstract][Full Text] [Related]
5. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT? Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies. Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173 [TBL] [Abstract][Full Text] [Related]
7. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma. Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617 [TBL] [Abstract][Full Text] [Related]
9. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience. Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886 [TBL] [Abstract][Full Text] [Related]
10. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography. Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses. Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings. Kunawudhi A; Wong AK; Alkasab TK; Mahmood U Asian Pac J Cancer Prev; 2016; 17(8):4143-7. PubMed ID: 27644675 [TBL] [Abstract][Full Text] [Related]
13. Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study. Manohar K; Bhattacharya A; Mittal BR Nucl Med Commun; 2013 Jun; 34(6):540-3. PubMed ID: 23503001 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial. Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379 [TBL] [Abstract][Full Text] [Related]
15. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients. Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135 [TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge? Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205 [TBL] [Abstract][Full Text] [Related]
19. Colonoscopic Findings in Patients With Incidental Colonic Focal FDG Uptake. Keyzer C; Dhaene B; Blocklet D; De Maertelaer V; Goldman S; Gevenois PA AJR Am J Roentgenol; 2015 May; 204(5):W586-91. PubMed ID: 25905966 [TBL] [Abstract][Full Text] [Related]
20. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis. Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]